Myriad Genetics's market cap is currently $1.33B. The company's EPS TTM is $-1.299; its P/E ratio is ―; Myriad Genetics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Jun 20
Income Statement
Total Revenue	$ 753.20M	$ 678.40M	$ 690.60M	$ 557.00M	$ 851.10M
Gross Profit	$ 517.00M	$ 476.40M	$ 493.00M	$ 378.80M	$ 650.10M
Operating Income	$ -257.40M	$ -123.70M	$ -48.70M	$ -194.80M	$ 7.60M
EBITDA	$ -186.10M	$ -67.80M	$ 14.10M	$ -123.40M	$ 86.10M
Net Income	$ -263.30M	$ -112.00M	$ -27.20M	$ -223.70M	$ 4.60M
Balance Sheet
Cash & Short-Term Investments	$ 140.90M	$ 114.90M	$ 339.80M	$ 150.70M	$ 136.90M
Total Assets	$ 1.15B	$ 1.20B	$ 1.32B	$ 1.42B	$ 1.56B
Total Debt	$ 152.10M	$ 145.00M	$ 92.30M	$ 0.00	$ 233.50M
Net Debt	$ 20.00M	$ 88.10M	$ -166.10M	$ -117.00M	$ 140.30M
Total Liabilities	$ 363.30M	$ 312.90M	$ 352.90M	$ 537.80M	$ 473.80M
Stockholders' Equity	$ 783.20M	$ 885.80M	$ 967.80M	$ 881.00M	$ 1.09B
Cash Flow
Free Cash Flow	$ -184.20M	$ -151.60M	$ 200.00K	$ -40.10M	$ 75.10M
Operating Cash Flow	$ -110.90M	$ -106.30M	$ 18.20M	$ -26.90M	$ 83.70M
Investing Cash Flow	$ 31.90M	$ -77.50M	$ 274.40M	$ 61.60M	$ -286.40M
Financing Cash Flow	$ 152.90M	$ -8.00M	$ -150.60M	$ -1.00M	$ 182.30M

Currency in USD

Myriad Genetics Earnings and Revenue History

Income Statement >

Myriad Genetics Debt to Assets

Balance Sheet >

Myriad Genetics Cash Flow

Cash Flow >

Myriad Genetics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing